DocSym
β
Searchsearch
Search
(C88.7) Other malignant immunoproliferative diseases
More details coming soon
161 489 in individuals diagnosis other malignant immunoproliferative diseases confirmed
32 609 deaths with diagnosis other malignant immunoproliferative diseases
20% mortality rate associated with the disease other malignant immunoproliferative diseases
Diagnosis other malignant immunoproliferative diseases is diagnosed Men are 19.23% more likely than Women
96 270
Men receive the diagnosis other malignant immunoproliferative diseases
20 804 (21.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
65 219
Women receive the diagnosis other malignant immunoproliferative diseases
11 805 (18.1 %)Died from this diagnosis.
Risk Group for the Disease other malignant immunoproliferative diseases - Men aged 60-64 and Women aged 75-79
In Men diagnosis is most often set at age 0-5, 15-19, 25-34, 40-94
Less common in men the disease occurs at Age 0-1, 5-14, 20-24, 35-39, 95+Less common in women the disease occurs at Age 0-5, 10-24, 35-39
In Women diagnosis is most often set at age 5-9, 25-34, 40-95+
Disease Features other malignant immunoproliferative diseases
Absence or low individual and public risk
Other malignant immunoproliferative diseases - what does this mean
Other malignant immunoproliferative diseases are a group of disorders characterized by an overproduction of abnormal immune cells. these cells can accumulate in the bone marrow, lymph nodes, and other organs, leading to organ damage and impaired functioning of the immune system.
What happens during the disease - other malignant immunoproliferative diseases
Other malignant immunoproliferative diseases are characterized by an abnormal increase in the number of cells of the immune system, which can lead to a variety of symptoms depending on the type of cell affected. these diseases are caused by genetic mutations that lead to the unregulated production of these cells, which can damage organs and tissues throughout the body and impair the body's ability to fight off infections.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete Blood Count (CBC)
- Bone Marrow Biopsy
- Immunophenotyping
- Cytogenetic Studies
- Flow Cytometry
- Immunoglobulin Electrophoresis
- Serum Protein Electrophoresis
- Lymph Node Biopsy
- Imaging Studies (CT scan, MRI, ultrasound)
Treatment and Medical Assistance
Main goal of the treatment: To reduce the number of abnormal cells and improve the patient's overall health.
- Administering chemotherapy and other drugs to kill the abnormal cells.
- Using radiation therapy to reduce the number of abnormal cells.
- Performing bone marrow transplantation to replace the abnormal cells with healthy ones.
- Using immunotherapy to stimulate the patient's immune system to fight the disease.
- Providing supportive care to manage symptoms and improve quality of life.
- Monitoring the patient's progress and making adjustments to the treatment plan as needed.
13 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Other malignant immunoproliferative diseases - Prevention
The best way to prevent other malignant immunoproliferative diseases is to maintain a healthy lifestyle, including a balanced diet, regular exercise, and avoiding smoking and excessive alcohol consumption. additionally, it is important to get regular check-ups and screenings to detect any early signs of the disease. vaccinations and immunizations are also recommended for those at risk of developing these diseases.